Tamiflu woes, obesity at a standstill, appendicitis mysteries and more from our Daily Briefing.
The American Red Cross, the largest supplier of donated blood in the U.S., was fined $9.6 million after federal inspectors found hundreds of blood safety violations at 16 of the organization’s 36 blood collection centers nationwide.
Recent studies have found statistical links between pesticide use and an outbreak of Parkinson's disease in California farm towns. Researchers even know which chemicals are the likely culprits. What's the government doing about it? Not much.
The impact of abortion on mental health, an end to some retiree health subsidies, and a postscript to the cantaloupe listeria outbreak, plus more from our Daily Briefing.
Issues surrounding sexuality can be a difficult topic for many people to openly discuss, but additional cultural barriers can make talking about subjects like HIV/AIDS almost impossible to broach.
Correcting a genetic defect before birth sounds like a great idea, but I'm uncomfortable with how we get there.
Cutting edge technology may be the game changer in controversial disease.
Every once in a while, a story not only finds a reporter, it hounds her. That was the case with my new book about two friends who blew the whistle on one of the deadliest prescription drugs in U.S. history.
The association of a murine retrovirus with ME/CFS appears to be no longer viable, but many of the researchers who can't find XMRV in patients still believe that other viruses are at play.
Researchers are finally starting to answer the question of whether hospital scrubs can pose a danger to patients — and people on the subway.
